Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kenneth Plunkitt

Clinical Cardiac Electrophysiology Naples, FL Medical Doctor

NPI 1053304436 CMS profile 320264

6376 Pine Ridge Rd Unit 180, Naples, FL 34119

Open in the dashboard

General payments

$12,297

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$269,553 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Kenneth Plunkitt of Naples, FL is reported in the CMS Open Payments database as having received $12,297 across 146 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $269,553 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 39th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $664 13
2024 General $788 27
2023 General $423 21
2022 General $434 23
2021 General $6,141 23
2020 General $3,361 24
2019 General $486 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Plunkitt
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Kenneth Plunkitt were reported at $664. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Kenneth Plunkitt Clinical Cardiac Electrophysiology median Middle half National median
2019 $486 $2,361 $585–$8,260 $163
2020 $3,361 $993 $247–$4,351 $114
2021 $6,141 $1,185 $326–$4,739 $132
2022 $434 $2,073 $554–$6,789 $149
2023 $423 $2,568 $759–$8,159 $160
2024 $788 $2,557 $703–$7,403 $164
2025 $664 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $10,483 82 payments
  2. CVRx, Inc. $743 34 payments
  3. CardioFocus, Inc. $337 2 payments
  4. Ge Healthcare $203 4 payments
  5. Impulse Dynamics (USA) Inc. $197 3 payments
  6. Janssen Pharmaceuticals, Inc $144 9 payments
  7. Alnylam Pharmaceuticals Inc. $57 2 payments
  8. Novartis Pharmaceuticals Corporation $42 2 payments
  9. Philips Electronics North America Corporation $35 2 payments
  10. Baudax Bio Inc. $23 1 payment
  11. Other $34 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,134 8 payments
  2. Consulting Fee $4,100 2 payments
  3. Food and Beverage $4,063 136 payments
Products named General payments · program years 2019–2025
  1. Nanostim Leadleas Pacemaker $2,652 6 payments
  2. Barostim Neo System $743 34 payments
  3. AVEIR Structural Heart $526 5 payments
  4. AVEIR Cardiac Rhythm Management $401 8 payments
  5. Mitra Clip system $320 2 payments
  6. XARELTO $144 9 payments
  7. AVEIR Structural Heart $127 4 payments
  8. Assurity Pacemaker $127 4 payments
  9. OPTIMIZER Cardiovascular Device $108 2 payments
  10. OPTIMIZER Cardiovascular Device $108 2 payments
  11. Other $972 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

205

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$114,051

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

47.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 67 $96,856
Xarelto Rivaroxaban Brand 18 $13,865
Flecainide Acetate Generic 34 $1,731
Metoprolol Succinate Generic 63 $1,142
Amiodarone Hcl Generic 11 $273
Sotalol Sotalol Hcl Brand 12 $184

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$579,026

Medicare's payments for the services billed

Medicare patients

2,195

Average age 80

Services billed

10,864

873 women, 1,322 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 73%
Ischemic heart disease 62%
Arthritis 56%
Heart failure 39%
Chronic kidney disease 32%
Diabetes 29%
Cancer 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record